Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6599
-0.0202 (-2.97%)
At close: May 30, 2025, 4:00 PM
0.6897
+0.0298 (4.52%)
Pre-market: Jun 2, 2025, 9:04 AM EDT

Immunic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
63906862251317
Upgrade
Market Cap Growth
-17.22%33.02%9.04%-75.28%-20.70%222.80%
Upgrade
Enterprise Value
49329-10142185
Upgrade
Last Close Price
0.661.001.501.409.5715.29
Upgrade
PB Ratio
-4.892.340.551.982.00
Upgrade
P/TBV Ratio
-4.892.340.552.672.52
Upgrade
Debt / Equity Ratio
-0.040.050.050.010.010.01
Upgrade
Quick Ratio
0.561.641.999.107.8115.37
Upgrade
Current Ratio
0.741.772.129.639.2115.93
Upgrade
Return on Equity (ROE)
-246.26%-424.44%-131.28%-100.01%-65.02%-40.54%
Upgrade
Return on Assets (ROA)
-101.26%-128.79%-68.13%-40.53%-30.30%-26.18%
Upgrade
Return on Capital (ROIC)
-158.54%-246.62%-85.24%-44.44%-32.31%-28.00%
Upgrade
Earnings Yield
-152.45%-111.58%-138.24%-193.89%-37.00%-13.89%
Upgrade
FCF Yield
-131.03%-94.39%-105.09%-105.08%-33.16%-14.61%
Upgrade
Buyback Yield / Dilution
-75.28%-126.03%-39.29%-34.52%-51.00%-102.84%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q